Use of 4-cyclopropylmethoxy-N--(3,5-di chloro1-oxidopyridin-4-yl)-5-(methoxy)pyridine -2-carboxamide for the treatment of motor disorders related to parkinson's disease

Details for Australian Patent Application No. 2008257322 (hide)

Owner SANOFI-AVENTIS

Inventors Menet, Christine; Poughon, Gilles; Ravinet-Trillou, Christine; Delay-Goyet, Philippe; Delgorge, Claire

Agent A J Park

Pub. Number AU-A-2008257322

PCT Pub. Number WO2008/145841

Priority 0702853 19.04.07 FR

Filing date 16 April 2008

Wipo publication date 4 December 2008

International Classifications

A61K 31/444 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/145841 Priority application(s): WO2008/145841

19 November 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)p yridine-2-carboxamide for the treatment of motor disorders related to Parkinson's disease

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008257323-Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof

2008257321-Use of 4-cyclopropylmethoxy-N-(3,5-dic hloro1-oxidopyridin-4-yl)-5-(methoxy)pyridine -2-carboxamide for the treatment of spinal cord traumas